Mechanisms of heart failure in obesity

Obesity Research and Clinical Practice

Volumn 8, Issue 6, 2014, Pages e540-e548

  Ebong, Imo A ^a   Goff, David C ^b   Rodriguez, Carlos J ^c   Chen, Haiying ^c   Bertoni, Alain G ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Global Health and Health Disparities   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Heart failure; Mechanisms; Obesity

Indexed keywords

ADIPOCYTOKINE; FATTY ACID; INSULIN; LIPID;

BODY MASS; CARDIOTOXICITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIASTOLE; DISEASE PREDISPOSITION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE MASS; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; KIDNEY DISEASE; LIPID STORAGE; LIPOTOXICITY; METABOLIC SYNDROME X; NONHUMAN; OBESITY; REVIEW; SLEEP DISORDERED BREATHING; SYSTOLE; VASOCONSTRICTION; WAIST CIRCUMFERENCE; WAIST HIP RATIO; COMPLICATION; FEMALE; MALE; PATHOPHYSIOLOGY;

BODY MASS INDEX; FEMALE; HEART FAILURE; HUMANS; LIPIDS; MALE; OBESITY;

EID: 84920179148     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2013.12.005     Document Type: Review

References (71)

1. H. Bahrami, R. Kronmal, D.A. Bluemke, J. Olson, S. Shea, and K. Liu Differences in the incidence of congestive heart failure by ethnicity. The multi-ethnic study of atherosclerosis Arch Intern Med 168 19 2008 2138 2145 [PMID: 18955644 ]
2. F. Braunschweig, M.R. Cowie, and A. Auricchio What are the costs of heart failure? Europace 13 Suppl. 2 2011 ii13 ii17 [PMID: 21518742 ]
3. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, and T.M. Brown Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 4 2011 e18 e209 [PMID: 21160056 ]
4. M.L. Baskin, J. Ard, F. Franklin, and D.B. Allison Prevalence of obesity in the United States Obes Rev 6 1 2005 5 7 [PMID: 156555032]
5. D.J. Glenn, F. Wang, M. Nishimoto, M.C. Cruz, Y. Uchida, and W.M. Holleran A murine model of isolated cardiac steatosis leads to cardiomyopathy Hypertension 57 2 2011 216 222 [PMID: 21220706 ]
6. H. Ashrafian, C.W. le Roux, A. Darzi, and T. Athanasiou Effects of bariatric surgery on cardiovascular function Circulation 118 20 2008 2091 2102 [PMID: 19001033 ]
7. R.S. Vasan Cardiac function and obesity Heart 89 10 2003 1127 1129 [PMID: 12975393 ]
8. P. Poirier, T.D. Giles, G.A. Bray, Y. Hong, J.S. Stern, and F.X. Pi-Sunyer Obesity and cardiovascular disease. Pathophysiology, evaluation and effect of weight loss Arterioscler Thromb Vasc Biol 26 5 2006 968 976 [PMID: 16627822 ]
9. M.A. Alpert Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome Am J Med Sci 321 4 2001 225 236 [PMID: 11307864 ]
10. M.A. Alpert, M.A. Fraley, J.A. Birchem, and N. Senkottaiyan Management of obesity cardiomyopathy Expert Rev Cardiovasc Ther 3 2 2005 225 230 [PMID: 15853596 ]
11. P. Poirier, T.D. Giles, G.A. Bray, Y. Hong, J.S. Stern, and F.X. Pi-Sunyer Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism Circulation 113 6 2006 898 918 [PMID: 16380542 ]
12. E. Avelar, T.V. Cloward, J.M. Walker, R.J. Farney, M. Strong, and R.C. Pendleton Left ventricular hypertrophy in severe obesity. Interactions among blood pressure, nocturnal hypoxemia, and body mass Hypertension 49 1 2007 34 39 [PMID: 17130310 ]
13. S. Kenchaiah, J.M. Gaziano, and R.S. Vasan Impact of obesity on the risk of heart failure and survival after the onset of heart failure Med Clin N Am 88 5 2004 1273 1294 [PMID: 15331317 ]
14. R.H. Eckel Obesity and heart disease. A statement for healthcare proffessionals from the Nutrition Committee, American Heart Association Circulation 96 9 1997 3248 3250 [PMID: 9386201]
15. P. Friberg, A. Allansdotter-Johnsson, A. Ambring, R. Ahl, H. Arheden, and J. Framme Increased left ventricular mass in obese adolescents Eur Heart J 25 11 2004 987 992 [PMID: 15172471 ]
16. C.J. Lavie, R.V. Milani, and H.O. Ventura Obesity and cardiovascular disease. Risk factor, paradox and impact of weight loss J Am Coll Cardiol 53 21 2009 1925 1932 [PMID: 19460605 ]
17. A.H. Gradman, and F. Alfayoumi From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease Prog Cardiovasc Dis 48 5 2006 326 341 [PMID: 16627048 ]
18. M.A. Bauml, and D.A. Underwood Left ventricular hypertrophy: an overlooked cardiovascular risk factor Clev Clin J Med 77 6 2010 381 387 [PMID: 20516249 ]
19. M. Karmazyn, D.M. Purdham, V. Rajapurohitam, and A. Zeidan Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart Cardiovasc Res 79 2 2008 279 286 [PMID: 18474523 ]
20. C.Y. Wong, T. O'Moore-Sullivan, R. Leano, N. Byrne, E. Beller, and T.H. Marwick Alterations of left ventricular myocardial characteristics associated with obesity Circulation 110 19 2004 3081 3087 [PMID: 15520317 ]
21. B. Berkalp, V. Cesur, D. Corapcioglu, C. Erol, and N. Baskal Obesity and left ventricular diastolic dysfunction Int J Cardiol 52 1 1995 23 26 [PMID: 8707431]
22. C. Russo, Z. Jin, S. Homma, T. Rundek, M.S. Elkind, and R.I. Sacco Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort J Am Coll Cardiol 57 12 2011 1368 1374 [PMID: 16490446 ]
23. S. Dorbala, S. Crugnale, D. Yang, and M.F. Di Carli Effect of body mass index on left ventricular cavity size and ejection fraction Am J Cardiol 97 5 2006 725 729 [PMID: 16490446 ]
24. B.A. Schoonderwoerd, M.D. Smit, L. Pen, and I.C. Van Gelder New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation' Europace 10 6 2008 668 673 [PMID: 18480076 ]
25. O. Asghar, U. Alam, S.A. Hayat, R. Aghamohammadzadeh, A.M. Heagerty, and R.A. Malik Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions Curr Cardiol Rev 8 4 2012 253 264 [PMID: 22920475 ]
26. O. Piot Atrial fibrillation and heart failure: a dangerous criminal conspiracy Ann Cardiol d'Angeiol 58 Suppl. 1 2009 S14 S16 [PMID: 20103171 ]
27. S. Scardi, and C. Mazzone Atrial fibrillation and heart failure: cause or effect? Ital Heart J Suppl 3 9 2002 899 907 [PMID: 12407857 ]
28. P. Poirier, and J.-P. Despres Waist circumference, visceral obesity, and cardiovascular risk J Cardiopulm Rehabil 23 3 2003 161 169 [PMID: 12782898 ]
29. J.A. Kim, M. Montagnani, S. Chandrasekran, and M.J. Quon Role of lipotoxicity in endothelial dysfunction Heart Fail Clin 8 4 2012 589 607 [PMID: 22999242 ]
30. J.D. Symons, and E.D. Abel Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide Rev Endocr Metab Disord 14 1 2013 59 68 [PMID: 23292334 ]
31. G.V. Russell, C.W. Pierce, and L. Nunley Financial implications of obesity Orthop Clin N Am 42 1 2011 123 127 [PMID: 21095441 ]
32. R.A. Hammond, and R. Levine The economic impact of obesity in the United States Diabetes Metab Syndr Obes 3 2010 285 295 [PMID: 21437097 ]
33. Y. Wang, X. Chen, Y. Song, B. Caballero, and L.J. Cheskin Association between obesity and kidney disease: a systematic review and meta-analysis Kidney Int 73 1 2008 19 33 [PMID: 17928825 ]
34. C.S. Dela Cruz, and R.A. Matthay Role of obesity in cardiomyopathy and pulmonary hypertension Clin Chest Med 30 3 2009 509 523 [PMID: 19700049 ]
35. J.-P. Baguet, G. Barone-Rochette, R. Tamisier, P. Levy, and J.L. Pepin Mechanisms of cardiac dysfunction in obstructive sleep apnea Nat Rev Cardiol 9 12 2012 679 688 [PMID: 23007221 ]
36. E. Ingelsson, J. Sundstrom, J. Arnlov, B. Zethelius, and L. Lind Insulin resistance and risk of congestive heart failure J Am Med Assoc 294 3 2005 334 341 [PMID: 16030278 ]
37. A.T. Turer, J.A. Hill, J.K. Elmquist, and P.E. Scherer Adipose tissue biology and cardiomyopathy. Translational implications Circ Res 111 12 2012 1565 1577 [PMID: 23223931 ]
38. T.B. Horwich, and G.C. Fonarow Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure J Am Coll Cardiol 55 4 2010 283 293 [PMID: 20117431 ]
39. C. Voulgari, N. Tentolouris, P. Dilaveris, D. Tousoulis, N. Katsilambros, and C. Stefanadis Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals J Am Coll Cardiol 58 13 2011 1343 1350 [PMID: 21920263 ]
40. C. Wong, and T.H. Marwick Obesity cardiomyopathy: pathogenesis and pathophysiology Nat Clin Pract Cardiovasc Med 4 8 2007 436 443 [PMID: 17653116 ]
41. K. Drosatos, and P.C. Schulze Cardiac lipotoxicity: molecular pathways and therapeutic implications Curr Heart Fail Rep 10 2 2013 109 121 [PMID: 2350876]
42. S. Banerjeee, and L.R. Peterson Myocardial metabolism and cardiac performance in obesity and insulin resistance Curr Cardiol Rep 9 2 2007 143 149 [PMID: 17430682 ]
43. L.R. Peterson Obesity and insulin resistance: effects on cardiac structure, function, and substrate metabolism Curr Hypertens Rep 8 6 2006 451 456 [PMID: 17087855 ]
44. P. Trayhurn, and I.S. Wood Signalling role of adipose tissue: adipokines and inflammation in obesity Biochem Soc Trans 33 Pt 5 2005 1078 1081 [PMID: 23761785 ]
45. S.C. Kang, B.R. Kim, S.Y. Lee, and T.S. Park Sphingolipid metabolism and obesity-induced inflammation Front Endocrinol 4 2013 67 [PMID: 23761785 ]
46. H. Bahrami, D.A. Bluemke, R. Kronmal, A.G. Bertoni, D.M. Lloyd-Jones, and E. Shahar Novel metabolic risk factors for incident heart failure and their relationship with obesity J Am Coll Cardiol 51 18 2008 1775 1783 [PMID: 18452784 ]
47. H.S. Sacks, and J.N. Fain Human epicardial fat: wht is new and what is missing? Clin Exp Pharmacol Physiol 38 12 2011 879 887 [PMID: 21895738 ]
48. K. Schram, and G. Sweeney Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure Cardiovasc Med 18 6 2008 199 205 [PMID: 19185809 ]
49. N. Ouchi, R. Shibata, and K. Walsh Cardioprotection by adiponectin Trends Cardiovasc Med 16 5 2006 141 146 [PMID: 16781946 ]
50. C.C.T. Smith, and D.M. Yellon Adipocytokines, cardiovascular pathophysiology and myocardial protection Pharmacol Ther 129 2 2011 206 219 [PMID: 20920528 ]
51. T.S. Park, and I.J. Goldberg Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure Heart Failure Clin 8 4 2012 633 641 [PMID: 22999245 ]
52. M. Karmazyn, D.M. Purdham, V. Rajapurohitam, and A. Zeidan Leptin as a cardiac hypertrophic factor: a potential target for therapeutics Trends Cardiovasc Med 17 6 2007 206 211 [PMID: 17662916 ]
53. C.C. Smith, M.M. Mocanu, S.M. Davidson, A.M. Wynne, J.C. Simpkin, and D.M. Yellon Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects Br J Pharmacol 149 1 2006 5 13 [PMID: 16847434 ]
54. D.S. Frankel, R.S. Vasan, R.B. D'Agostino Sr., E.J. Benjamin, D. Levy, and T.J. Wang Resistin, adiponectin and risk of heart failure. The framingham offspring study J Am Coll Cardiol 53 9 2009 754 762 [PMID: 19245965 ]
55. L.S. Szczepaniak, R.L. Dobbins, G.J. Metzger, G. Sartoni-D'Ambrosia, D. Arbique, and W. Vongpatanasin Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging Magn Reson Med 49 3 2003 417 423 [PMID: 12594743 ]
56. I.A. Ebong, D.C. Goff, C.J. Rodriguez, H. Chen, C.T. Sibley, and A.G. Bertoni Association of lipids with incident heart failure among adults with and without diabetes mellitus. Multiethnic study of atherosclerosis Circ Heart Fail 6 3 2013 371 378 [PMID: 23529112 ]
57. J.M. McGavock, R.J. Victor, R.H. Unger, Szczepaniak, and American College of Physicians and Ameican Physiological Society Adiposity of the heart∗. Revisited Ann Intern Med 144 7 2006 517 524 [PMID: 16585666 ]
58. A.R. Wende, and E.D. Abel Lipotoxicity in the heart Biochim Biophys Acta 1801 3 2009 311 319 [PMID: 19818871 ]
59. J.E. Schaffer Lipotoxicity: when tissues overeat Curr Opin Lipidol 14 3 2003 281 287 [PMID: 12840659 ]
60. T.S. Park, Y. Hu, H.L. Noh, K. Drosatos, K. Okajima, and J. Buchanan Ceramide is a cardiotoxin in lipotoxic cardiomyopathy J Lipid Res 49 10 2008 2101 2112 [PMID: 18515784 ]
61. M. Baranowski, and J. Gorski Heart sphingolipids in health and disease Adv Exp Med Biol 721 2011 41 56 [PMID: 21910081 ]
62. H.E. Bays Adisopathy: is "sick fat" a cardiovascular disease? J Am Coll Cardiol 57 25 2011 2461 2473 [PMID: 21679848 ]
63. E. Zamora, J. Lupon, M. de Antonio, A. Urrutia, R. Coll, and C. Diez The obesity paradox in heart failure: is etiology a key factor? Int J Cardiol 166 3 2013 601 605 [PMID: 22204855 ]
64. I.A. Ebong, D.C. Goff, C.J. Rodriguez, H. Chen, D.A. Bluemke, and M. Szklo The relationship between measures of obesity and incident heart failure: the multi-ethnic study of atherosclerosis Obesity 21 9 2013 1915 1922 [PMID: 23441088 ]
65. A.L. Clark, J. Chyu, and T.B. Horwich The obesity paradox in men versus women with systolic heart failure Am J Cardiol 110 1 2012 77 82 [PMID: 22497678 ]
66. A.L. Clark, G.C. Fonarow, and T.B. Horwich Waist circumference, body mass index and survival in systolic heart failure: the obesity paradox revisited J Cardiac Fail 17 5 2011 374 380 [PMID: 21549293 ]
67. C.J. Lavie, R.V. Milani, H.O. Ventura, and A. Romero-Corral Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in "obesity paradox" Mayo Clin Proc 85 7 2010 605 608 [PMID: 20592168 ]
68. P.B. Soeters, and L. Sobotka The pathophysiology underlying the obesity paradox Nutrition 28 6 2012 613 615 [PMID: 22222294 ]
69. G.C. Linssen, S.J. Bakker, A.A. Voors, R.T. Gansevoort, H.L. Hillege, and P.E. de Jong N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population Eur Heart J 31 1 2010 120 127 [PMID: 19854731 ]
70. A. Palazzuoli, M. Gallota, I. Quatrini, and R. Nuti Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure Vasc Health Risk Manage 6 2010 411 418 [PMID: 20539843 ]
71. A.G. Bertoni, L.E. Wagenknecht, D.W. Kitzman, S.M. Marcovina, J.T. Rushing, and M.A. Espeland Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes Obesity 20 7 2012 1511 1518 [PMID: 21959345 ]